Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS Document date: 2018_12_19
ID: r79h9yzz_413
Snippet: Based on human monitoring standards, clopidogrel's therapeutic efficacy decreases during sustained administration in dogs. Prednisone coâ€administration increases antiplatelet effects of clopidogrel therapy, increasing the risk of overcontrol at dosages currently used for management of immuneâ€mediated hemolytic anemia. Platelet reactivity should be monitored during sustained clopidogrel therapy to avoid over†or undertreatment......
Document: Based on human monitoring standards, clopidogrel's therapeutic efficacy decreases during sustained administration in dogs. Prednisone coâ€administration increases antiplatelet effects of clopidogrel therapy, increasing the risk of overcontrol at dosages currently used for management of immuneâ€mediated hemolytic anemia. Platelet reactivity should be monitored during sustained clopidogrel therapy to avoid over†or undertreatment.
Search related documents:
Co phrase search for related documents- antiplatelet effect and clopidogrel therapy antiplatelet effect: 1
- clopidogrel therapy and hemolytic anemia: 1, 2
- clopidogrel therapy and platelet reactivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- clopidogrel therapy and sustained clopidogrel therapy: 1, 2, 3, 4
- hemolytic anemia and platelet reactivity: 1
- hemolytic anemia and sustained administration: 1
- hemolytic anemia and sustained clopidogrel therapy: 1
- hemolytic anemia and therapeutic efficacy: 1
Co phrase search for related documents, hyperlinks ordered by date